The Kansas City, Kansas, company received a loan that will fund operations through next year, when it aims to submit its ADHD drug for FDA approval.Cingulate secures capital ahead of 2025 plans to submit drug for FDA approval
The Kansas City, Kansas, company received a loan that will fund operations through next year, when it aims to submit its ADHD drug for FDA approval.